Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 30825834 | HLA-G (HLA-G) | liver fibrosis | NA | NA | NA | only_studied | |
| here, we investigated the role of hla-g and mast cells in liver fibrosis, focusing, in particular, on interactions between human mast and stellate cells. | |||||||
| 30825834 | HLA-G (HLA-G) | liver fibrosis | NA | NA | NA | unclassified | |
| mast cells play a beneficial, anti-fibrotic role in liver fibrosis, via the hla-g-mediated decrease of collagen i. | |||||||
| 34369253 | HLA-C (HLA-C) | liver fibrosis | NA | NA | NA | only_studied | |
| finally, we discussed novel markers for monitoring the response to specific treatments (hla-c 06, plc, tarc, nlr, and plr) as well as potentially useful biomarkers for evaluation of therapy-associated adverse events (liver fibrosis-related markers). | |||||||
| 10213306 | HLA (HLA) | men 3 | NA | NA | NA | positive | |
| in the group of infertile men 37 (24%) were hsv-dna positive but none of the fertile control (0%) was positive; (3) treatment of both partners with an antiviral drug resulted in two pregnancies; (4) hla data on four of the couples in which the wife's menstrual blood was hsv positive was compared to seven hsv negative couples and 22 infertile, as well as 22 fertile couples. | |||||||
| 11713101 | HLA-DR (HLA-DR) | indomethacin | NA | prostaglandin | NA | unclassified | |
| NA | |||||||
| 12242516 | HLA-A*02 | gastrointestinal cancer | NA | NA | NA | unclassified | |
| induction of specific ctl by mage-3/cea peptide-pulsed dendritic cells from hla-a2/a24(+) gastrointestinal cancer patients. | |||||||
| 12242516 | HLA-A*24 | gastrointestinal cancer | NA | NA | NA | unclassified | |
| induction of specific ctl by mage-3/cea peptide-pulsed dendritic cells from hla-a2/a24(+) gastrointestinal cancer patients. | |||||||
| 16446550 | HLA-A*24 | gastrointestinal cancer | Japanese | NA | NA | unclassified | |
| a newly identified mage-3-derived, hla-a24-restricted peptide is naturally processed and presented as a ctl epitope on mage-3-expressing gastrointestinal cancer cells. | |||||||
| 16446550 | HLA-A*24 | gastrointestinal cancer | Japanese | NA | NA | unclassified | |
| in the present study, we defined a new mage-3 derived, hla-a24-binding peptide presented as a ctl epitope on gastrointestinal cancer cells.materials and a panel of mage-3-derived peptides (9mer and 10mer) with the hla-a24-binding motif was selected, and identification of mage-3-derived, hla-a24-restricted ctl epitopes was performed by a reverse immunology approach. | |||||||
| 10232738 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | peripheral blood stem cell transplantations | NA | NA | NA | unclassified | |
| to detect the effect of the stem cell source, allogeneic peripheral blood stem cell transplantations (allopbscts) performed between 1995 and 1997 from human leukocyte antigen (hla)-identical siblings in 40 patients with acute and chronic hematological disorders were compared with a historical group of 40 patients with similar variables who had received allogeneic bone marrow transplants (allobmts) between 1993 and 1995. | |||||||
Copyright 2024